Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-HPV58 L1/Major capsid protein L1 (Iv0004) (VVV19403)

Host species:Human
Isotype:IgG1
Applications:ELISA, Neutralization
Accession:P26535
Overview

Catalog No.

VVV19403

Species reactivity

Human papillomavirus 58

Host species

Human

Isotype

IgG1

Clonality

Monoclonal

Target

Major capsid protein L1, L1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P26535

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

Iv0004

Data Image
  • SDS-PAGE
    SDS PAGE for HPV58 L1/Major capsid protein L1 (Iv0004)
References

Development of HPV58 type-specific antibodies and detection kit. PMID: 35465823

Prevalence of human papillomavirus variants and genetic diversity in the L1 gene and long control region of HPV16, HPV31, and HPV58 found in North-East Brazil. PMID: 25793187

Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency. PMID: 33636291

[Expression of the human papillomavirus type 58L1 capsid protein in E.coli and preparation of the HPV58 L1 mouse antiserum]. PMID: 11986714

Combined truncations at both N- and C-terminus of human papillomavirus type 58 L1 enhanced the yield of virus-like particles produced in a baculovirus system. PMID: 34890711

L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis. PMID: 27717385

Codon optimization of the human papillomavirus type 58 L1 gene enhances the expression of soluble L1 protein in Saccharomyces cerevisiae. PMID: 23183918

Characteristics of human papillomavirus infection among females and the genetic variations of HPV18 and HPV58 in Henan province, China. PMID: 36755053

The production and immunogenicity of human papillomavirus type 58 virus-like particles produced in Saccharomyces cerevisiae. PMID: 23124750

Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China. PMID: 23372836

Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58. PMID: 27708433

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles. PMID: 27147749

HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study. PMID: 35945577

[Carboxyl terminus truncated HPV58 virus L1 protein expressed with baculovirus system and its bioactivity]. PMID: 15968984

[Construction of prophylactic recombinant HPV58-attenuated Shigella vector live vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model]. PMID: 18062891

Phylogeographic analysis of human papillomavirus 58. PMID: 20016974

Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PMID: 21673791

Development of prophylactic recombinant HPV58-attenuated Shigella live vector vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model. PMID: 19204831

An optimized yeast cell-free system: sufficient for translation of human papillomavirus 58 L1 mRNA and assembly of virus-like particles. PMID: 18691524

Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia. PMID: 23871162

The preparation of human papillomavirus type 58 vaccine and exploring its biological activity and immunogenicity in vitro. PMID: 21738041

Genetic diversity and bioinformatic analysis in the L1 gene of HPV genotypes 31, 33, and 58 circulating in women with normal cervical cytology. PMID: 36959610

Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity. PMID: 31281327

Prevalence of Human Papillomavirus Genotypes in Pterygia from Thai Individuals. PMID: 33736562

Genetic signatures for lineage/sublineage classification of HPV16, 18, 52 and 58 variants. PMID: 33238224

L1 sequence of a new human papillomavirus type-58 variant associated with cervical intraepithelial neoplasia. PMID: 15665981

[Preparation and identification of type specific and conformation dependent HPV16 L1 protein monoclonal antibody.]. PMID: 19961800

Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus. PMID: 28951471

Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins. PMID: 25203446

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70. PMID: 36316367

A Comparative Study on Delivery of Externally Attached DNA by Papillomavirus VLPs and Pseudoviruses. PMID: 34960247

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. PMID: 12050360

Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58. PMID: 20181746

Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies. PMID: 20334659

Impact of Naturally Occurring Variation in the Human Papillomavirus 58 Capsid Proteins on Recognition by Type-Specific Neutralizing Antibodies. PMID: 29905865

Prevalence of human papillomavirus types and phylogenetic analysis of HPV-16 L1 variants from Southern India. PMID: 25773853

Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines. PMID: 23722024

Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer. PMID: 30353680

Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015-2021 and the genetic variability of HPV16 and 52. PMID: 35246180

T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancer. PMID: 20668141

Human papillomavirus 16L1-58L2 chimeric virus-like particles elicit durable neutralizing antibody responses against a broad-spectrum of human papillomavirus types. PMID: 28968993

Prevalence of human papillomavirus types in cervical cancerous and precancerous lesions of Ecuadorian women. PMID: 26113443

Genome sequencing accuracy by RCA-seq versus long PCR template cloning and sequencing in identification of human papillomavirus type 58. PMID: 24410913

Characterization of Human Papillomavirus 16 from Kinshasa (Democratic Republic of the Congo)-Implications for Pathogenicity and Vaccine Effectiveness. PMID: 36557745

Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay. PMID: 21068278

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-HPV58 L1/Major capsid protein L1 (Iv0004) [VVV19403]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only